An immuno-oncology targeting panel accurately characterized tumor-resident immune cells and located pathologically and clinically relevant tumor microenvironment features. Cancer development and ...

Therefore DC CTLA-4+ EVs act in a paracrine and autocrine fashion to downregulate immune responses. Additionally, siRNA ablation of DC CTLA-4 leads to increased efficacy of a DC vaccine to mount an ...